Andra Ap Fonden Teva Pharmaceutical Industries LTD Transaction History

Andra Ap Fonden

$6.64 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$8.36 - $11.37 $4.34 Million - $5.91 Million	519,700 Added 68.36%	1,279,900 $11.3 Million
Q4 2022 Feb 13, 2023	BUY	$7.95 - $9.48 $2.99 Million - $3.57 Million	376,100 Added 97.92%	760,200 $6.93 Million
Q3 2022 Nov 14, 2022	SELL	$6.86 - $11.95 $1.07 Million - $1.86 Million	-155,600 Reduced 28.83%	384,100 $3.1 Million
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $3.18 Million - $4.48 Million	-431,200 Reduced 44.41%	539,700 $4.06 Million
Q4 2021 Feb 15, 2022	BUY	$7.9 - $10.19 $4.36 Million - $5.63 Million	552,200 Added 131.88%	970,900 $7.78 Million
Q3 2021 Nov 12, 2021	SELL	$8.38 - $10.18 $2.13 Million - $2.59 Million	-254,500 Reduced 37.8%	418,700 $4.08 Million
Q2 2021 Aug 16, 2021	SELL	$9.9 - $11.56 $155,430 - $181,492	-15,700 Reduced 2.28%	673,200 $6.67 Million
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $524,238 - $649,467	50,700 Added 7.94%	688,900 $7.95 Million
Q4 2020 Feb 12, 2021	BUY	$8.61 - $11.04 $3.21 Million - $4.11 Million	372,600 Added 140.29%	638,200 $6.16 Million
Q3 2020 Nov 12, 2020	SELL	$8.57 - $12.69 $2.09 Million - $3.09 Million	-243,500 Reduced 47.83%	265,600 $2.39 Million
Q2 2020 Aug 06, 2020	BUY	$8.12 - $13.12 $712,935 - $1.15 Million	87,800 Added 20.84%	509,100 $6.28 Million
Q1 2020 May 13, 2020	SELL	$6.69 - $13.45 $400,731 - $805,655	-59,900 Reduced 12.45%	421,300 $3.78 Million
Q4 2019 Feb 10, 2020	BUY	$6.53 - $10.72 $654,306 - $1.07 Million	100,200 Added 26.3%	481,200 $4.72 Million
Q3 2019 Nov 19, 2019	SELL	$6.16 - $9.6 $1.27 Million - $1.99 Million	-206,900 Reduced 35.19%	381,000 $2.62 Million
Q2 2019 Aug 15, 2019	BUY	$8.12 - $15.72 $1.54 Million - $2.98 Million	189,300 Added 47.49%	587,900 $5.43 Million
Q1 2019 May 14, 2019	BUY	$15.58 - $20.01 $613,852 - $788,394	39,400 Added 10.97%	398,600 $6.25 Million
Q3 2018 Oct 16, 2018	BUY	$21.06 - $25.65 $4.5 Million - $5.48 Million	213,700 Added 146.87%	359,200 $7.74 Million
Q2 2018 Aug 17, 2018	SELL	$16.77 - $24.71 $1.67 Million - $2.46 Million	-99,700 Reduced 40.66%	145,500 $3.54 Million
Q1 2018 Apr 10, 2018	BUY	$16.68 - $22.07 $2.87 Million - $3.8 Million	172,200 Added 235.89%	245,200 $4.19 Million
Q4 2017 Feb 14, 2018	BUY	$11.23 - $19.1 $683,907 - $1.16 Million	60,900 Added 503.31%	73,000 $1.38 Million
Q3 2017 Oct 31, 2017	BUY	$15.41 - $32.17 $186,461 - $389,257	12,100	12,100 $213,000

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

Black Rock Inc. New York, NY

43M
Shares

$950 Million
0.02% of portfolio
Ion Asset Management Ltd. George Town, Grand Cayman, E9

36.2M
Shares

$801 Million
35.87% of portfolio
Clal Insurance Enterprises Holdings LTD Tel Aviv, L3

34.5M
Shares

$763 Million
5.5% of portfolio
Menora Mivtachim Holdings Ltd.

28.8M
Shares

$637 Million
3.32% of portfolio
Exor Capital LLP London, X0

26.5M
Shares

$585 Million
14.79% of portfolio

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account